羚锐制药：董事减持股份计划公告

Group 1 - The company Lingrui Pharmaceutical announced that as of the date of the announcement, its director and deputy general manager, Ms. Chen Yan, holds 965,000 shares, accounting for 0.17% of the total share capital [2] - Ms. Chen Yan plans to reduce her holdings by up to 200,000 shares, which represents no more than 0.0353% of the company's total share capital and no more than 25% of her total shareholdings, within three months after the disclosure of this reduction plan [2] - The reduction will be executed through centralized bidding and the selling price will be determined based on the market price at the time of the reduction [2]